Using Droplet Digital™ PCR for Cancer and Liquid Biopsy Studies

For more info, visit Droplet Digital PCR (ddPCR™) technology is being used to identify cancer subtypes, optimize drug treatment plans, monitor residual disease, and study tumor evolution. ddPCR assays offer advantages in the field of liquid biopsies, enablingto the measurement of circulating nucleic acids (cfDNA) and circulating tumor cells (CTCs) in blood. ddPCR can detect rare tumorigenic mutations in a high background of normal DNA, routinely down to 0